Serine/arginine-rich protein 30c activates human papillomavirus type 16 L1 mRNA expression via a bimodal mechanism

Journal of General Virology

Volumn 92, Issue 10, 2011, Pages 2411-2421

  Somberg, Monika ^a,d   Li, Xiaoze ^a,b   Johansson, Cecilia ^a   Orru, Beatrice ^c   Chang, Roger ^a   Rush, Margaret ^a   Fay, Joanna ^c   Ryan, Fergus ^c   Schwartz, Stefan ^a,b,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^d OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; MESSENGER RNA; SERINE ARGININE RICH PROTEIN; VIRUS RNA;

ARTICLE; HUMAN PAPILLOMAVIRUS TYPE 16; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA ANALYSIS; RNA SPLICING; VIRUS EXPRESSION; VIRUS GENOME;

CAPSID PROTEINS; GENE EXPRESSION; HELA CELLS; HUMANS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; RNA SPLICING; RNA, MESSENGER; RNA-BINDING PROTEINS;

HUMAN PAPILLOMAVIRUS TYPE 16; MIRIDAE;

EID: 80052922847     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.033183-0     Document Type: Article

References (39)

1. Baker, C. & Calef, C. (1997). Maps of papillomavirus mRNA transcripts. In Human Papillomaviruses: a Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Edited by S. R. Billakanti, C. E. Calef, A. D. Farmer, A. L. Halpern & G. L. Myers. Los Alamos, NM: Los Alamos National Laboratory.
2. Collier, B., Goobar-Larsson, L., Sokolowski, M. & Schwartz, S. (1998). Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2. J Biol Chem 273, 22648-22656.
3. Collier, B., Öberg, D., Zhao, X. & Schwartz, S. (2002). Specific inactivation of inhibitory sequences in the 59 end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells. J Virol 76, 2739-2752.
4. Cumming, S. A., Repellin, C. E., McPhillips, M., Radford, J. C., Clements, J. B. & Graham, S. V. (2002). The human papillomavirus type 31 late 39 untranslated region contains a complex bipartite negative regulatory element. J Virol 76, 5993-6003.
5. Doorbar, J. (2005). The papillomavirus life cycle. J Clin Virol 32 (Suppl. 1), S7-S15.
6. Estmer Nilsson, C., Petersen-Mahrt, S., Durot, C., Shtrichman, R., Krainer, A. R., Kleinberger, T. & Akusjärvi, G. (2001). The adenovirus E4-ORF4 splicing enhancer protein interacts with a subset of phosphorylated SR proteins. EMBO J 20, 864-871.
7. Fay, J., Kelehan, P., Lambkin, H. & Schwartz, S. (2009). Increased expression of cellular RNA-binding proteins in HPV-induced neoplasia and cervical cancer. J Med Virol 81, 897-907.
8. Goraczniak, R. & Gunderson, S. I. (2008). The regulatory element in the 39-untranslated region of human papillomavirus 16 inhibits expression by binding CUG-binding protein 1. J Biol Chem 283, 2286-2296.
9. Graham, S. V. (2008). Papillomavirus 39 UTR regulatory elements. Front Biosci 13, 5646-5663.
10. Howley, P. M. & Lowy, D. R. (2001). Papillomaviruses and their replication. In Fields Virology, 4th edn, pp. 2197-2229. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
11. Huang, T. S., Nilsson, C. E., Punga, T. & Akusjärvi, G. (2002). Functional inactivation of the SR family of splicing factors during a vaccinia virus infection. EMBO Rep 3, 1088-1093.
12. Jia, R., Liu, X., Tao, M., Kruhlak, M., Guo, M., Meyers, C., Baker, C. C. & Zheng, Z. M. (2009). Control of the papillomavirus early-to-late switch by differentially expressed SRp20. J Virol 83, 167-180.
13. Johansson, C., Zhao, H., Bajak, E., Granberg, F., Pettersson, U. & Svensson, C. (2005). Impact of the interaction between adenovirus E1A and CtBP on host cell gene expression. Virus Res 113, 51-63.
14. Kanopka, A., Mühlemann, O. & Akusjärvi, G. (1996). Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature 381, 535-538.
15. Kanopka, A., Mühlemann, O., Petersen-Mahrt, S., Estmer, C., Öhrmalm, C. & Akusjärvi, G. (1998). Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins. Nature 393, 185-187.
16. Koffa, M. D., Graham, S. V., Takagaki, Y., Manley, J. L. & Clements, J. B. (2000). The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels. Proc Natl Acad Sci U S A 97, 4677-4682.
17. Longworth, M. S. & Laimins, L. A. (2004). Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 68, 362-372.
18. McPhillips, M. G., Veerapraditsin, T., Cumming, S. A., Karali, D., Milligan, S. G., Boner, W., Morgan, I. M. & Graham, S. V. (2004). SF2/ ASF binds the human papillomavirus type 16 late RNA control element and is regulated during differentiation of virus-infected epithelial cells. J Virol 78, 10598-10605.
19. Milligan, S. G., Veerapraditsin, T., Ahamet, B., Mole, S. & Graham, S. V. (2007). Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells. Virology 360, 172-181.
20. Oberg, D., Collier, B., Zhao, X. & Schwartz, S. (2003). Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells. J Virol 77, 11674-11684.
21. Oberg, D., Fay, J., Lambkin, H. & Schwartz, S. (2005). A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H. J Virol 79, 9254-9269.
22. Raffetseder, U., Frye, B., Rauen, T., Jürchott, K., Royer, H.-D., Jansen, P. L. & Mertens, P. R. (2003). Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection. J Biol Chem 278, 18241-18248.
23. Rush, M., Zhao, X. & Schwartz, S. (2005). A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression. J Virol 79, 12002-12015.
24. Schwartz, S. (2008). HPV-16 RNA processing. Front Biosci 13, 5880-5891.
25. Skalweit, A., Doller, A., Huth, A., Kähne, T., Persson, P. B. & Thiele, B. J. (2003). Posttranscriptional control of renin synthesis: identification of proteins interacting with renin mRNA 39-untranslated region. Circ Res 92, 419-427.
26. Sokolowski, M. & Schwartz, S. (2001). Heterogeneous nuclear ribonucleoprotein C binds exclusively to the functionally important UUUUU-motifs in the human papillomavirus type-1 AU-rich inhibitory element. Virus Res 73, 163-175.
27. Sokolowski, M., Zhao, C., Tan, W. & Schwartz, S. (1997). AU-rich mRNA instability elements on human papillomavirus type 1 late mRNAs and c-fos mRNAs interact with the same cellular factors. Oncogene 15, 2303-2319.
28. Sokolowski, M., Furneaux, H. & Schwartz, S. (1999). The inhibitory activity of the AU-rich RNA element in the human papillomavirus type 1 late 39 untranslated region correlates with its affinity for the elav-like HuR protein. J Virol 73, 1080-1091.
29. Somberg, M. & Schwartz, S. (2010). Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 39-splice site on the HPV-16 genome. J Virol 84, 8219-8230.
30. Somberg, M., Zhao, X., Fröhlich, M., Evander, M. & Schwartz, S. (2008). Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 59 splice site, SD3632. J Virol 82, 3665-3678.
31. Somberg, M., Rush, M., Fay, J., Ryan, F., Lambkin, H., Akusjärvi, G. & Schwartz, S. (2009). Adenovirus E4orf4 induces HPV-16 late L1 mRNA production. Virology 383, 279-290.
32. Terhune, S. S., Hubert, W. G., Thomas, J. T. & Laimins, L. A. (2001). Early polyadenylation signals of human papillomavirus type 31 negatively regulate capsid gene expression. J Virol 75, 8147-8157.
33. Tranell, A., Fenyö, E. M. & Schwartz, S. (2010). Serine- and argininerich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 59-splice site of exon 3. J Biol Chem 285, 31537-31547.
34. Wiklund, L., Sokolowski, M., Carlsson, A., Rush, M. & Schwartz, S. (2002). Inhibition of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability element in the HPV-1 late 39 untranslated region. J Biol Chem 277, 40462-40471.
35. Zhao, X., Rush, M. & Schwartz, S. (2004). Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene. J Virol 78, 10888-10905.
36. Zhao, X., Öberg, D., Rush, M., Fay, J., Lambkin, H. & Schwartz, S. (2005). A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein. J Virol 79, 4270-4288.
37. Zhao, X., Rush, M., Carlsson, A. & Schwartz, S. (2007). The presence of inhibitory RNA elements in the late 39-untranslated region is a conserved property of human papillomaviruses. Virus Res 125, 135-144.
38. Zheng, Z. M. & Baker, C. C. (2006). Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci 11, 2286-2302.
39. zur Hausen, H. (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2, 342-350.